Marjolein K. Sechterberger

Upfront Genotyping of <i>DPYD</i>*<i>2A</i> to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis

Maarten J. Deenen, Didier Meulendijks, Annemieke Cats et al. · Journal of Clinical Oncology · 2015 · 345 citations · Full text

Medicine, Oncology, Pharmacology +17

The effect of diabetes mellitus on the association between measures of glycaemiccontrol and ICU mortality: a retrospective cohort study

Marjolein K. Sechterberger, Robert J. Bosman, Heleen M. Oudemans–van Straaten et al. · Critical Care · 2013 · 131 citations · Full text

Medicine, Endocrinology, Diabetology +14

Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial

Daphne T. Boom, Marjolein K. Sechterberger, Saskia Rijkenberg et al. · Critical Care · 2014 · 111 citations · Full text

Medicine, Critical Care Nursing, Continuity Of Care +16

Glycemic Effects of a Low‐Carbohydrate Enteral Formula Compared With an Enteral Formula of Standard Composition in Critically Ill Patients: An Open‐Label Randomized Controlled Clinical Trial

Sigrid C. van Steen, Saskia Rijkenberg, Marjolein K. Sechterberger et al. · Journal of Parenteral and Enteral Nutrition · 2017 · 33 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +17

Accuracy of Intra-arterial and Subcutaneous Continuous Glucose Monitoring in Postoperative Cardiac Surgery Patients in the ICU

Marjolein K. Sechterberger, Peter H. J. van der Voort, Paul J. Strasma et al. · Journal of Diabetes Science and Technology · 2014 · 31 citations · Full text

Medicine, Biomedical Engineering, Surgery +17